These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15088769)

  • 61. Influenza and the work of the World Health Organization.
    Kitler ME; Gavinio P; Lavanchy D
    Vaccine; 2002 May; 20 Suppl 2():S5-14. PubMed ID: 12110248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The global agenda on influenza surveillance and control.
    Stöhr K
    Vaccine; 2003 May; 21(16):1744-8. PubMed ID: 12686087
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comprehensive hands-on training for influenza vaccine manufacturing: a WHO-BARDA-BTEC partnership for global workforce development.
    Ruiz J; Gilleskie GL; Brown P; Burnett B; Carbonell RG
    Biochem Mol Biol Educ; 2014; 42(5):414-9. PubMed ID: 25132407
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance.
    Williams RJ; Cox NJ; Regnery HL; Noah DL; Khan AS; Miller JM; Copley GB; Ice JS; Wright JA
    Mil Med; 1997 Feb; 162(2):82-6. PubMed ID: 9038023
    [TBL] [Abstract][Full Text] [Related]  

  • 65. WHO Global Influenza Programme: survey on capacities of national influenza centres, January-June 2002.
    Wkly Epidemiol Rec; 2002 Oct; 77(42):350-6. PubMed ID: 12407818
    [No Abstract]   [Full Text] [Related]  

  • 66. WHO Expert Committee on biological standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (963):1-244. PubMed ID: 22420130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transfer of technology for production of rabies vaccine: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(4):661-6. PubMed ID: 3878738
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Using combinatorial bioinformatics methods to analyze annual perspective changes of influenza viruses and to accelerate development of effective vaccines.
    Hu YJ; Chow KC; Liu CC; Lin LJ; Wang SC; Wang SD
    J Formos Med Assoc; 2015 Aug; 114(8):774-8. PubMed ID: 26044364
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Global respiratory virus surveillance: strengths, gaps, and way forward.
    Gupta S; Gupta T; Gupta N
    Int J Infect Dis; 2022 Aug; 121():184-189. PubMed ID: 35584744
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of the World Health Organization in the study of influenza.
    Kaplan MM
    Philos Trans R Soc Lond B Biol Sci; 1980 Feb; 288(1029):417-21. PubMed ID: 6103559
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influenza: the WHO programme.
    WHO Chron; 1979 Jan; 33(1):7-8. PubMed ID: 425480
    [No Abstract]   [Full Text] [Related]  

  • 72. [The role of genetic and molecular characterization of viruses which concern the surveillance and epidemiology of influenza: WHO memorandum].
    Bull World Health Organ; 1982; 60(2):193-8. PubMed ID: 6980731
    [No Abstract]   [Full Text] [Related]  

  • 73. Harmonization of requirements for influenza virus vaccines: the first year's experience with the EEC guideline.
    Damen JE
    Biologicals; 1993 Jun; 21(2):179-82. PubMed ID: 8297602
    [TBL] [Abstract][Full Text] [Related]  

  • 74. World Health Organization, 50 years of influenza surveillance: a challenge for the 21st century. Meeting 17-19 February 1999, WHO, Geneva.
    Bruntland GH
    Vaccine; 2002 May; 20 Suppl 2():S1-4. PubMed ID: 12110247
    [No Abstract]   [Full Text] [Related]  

  • 75. [Progress on the development of anti-influenza vaccines: memorandum from a WHO meeting].
    Bull World Health Organ; 1987; 65(4):465-70. PubMed ID: 3500798
    [No Abstract]   [Full Text] [Related]  

  • 76. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals: application to influenza vaccine production.
    Griffiths E
    Dev Biol Stand; 1999; 98():153-7; discussion 167. PubMed ID: 10494968
    [No Abstract]   [Full Text] [Related]  

  • 77. Global Funders Consortium for Universal Influenza Vaccine Development.
    Bresee JS; McKinlay MA; Abramson J; Klugman KP; Wairagkar N;
    Vaccine; 2019 Jan; 37(2):211-213. PubMed ID: 30503660
    [No Abstract]   [Full Text] [Related]  

  • 78. The WHO network of collaborating centres on standardization and regulatory evaluation of vaccines.
    Knezevic I; Griffiths E; Petricciani J; Bramley D
    Biologicals; 2012 Nov; 40(6):499-506. PubMed ID: 22901945
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005.
    Cassetti MC; Katz JM; Wood J
    Vaccine; 2006 Jan; 24(5):541-3. PubMed ID: 16493789
    [No Abstract]   [Full Text] [Related]  

  • 80. Influenza vaccine programme using the hypospray jet injector method.
    Wright M
    Occup Health (Lond); 1968; 20(5):254-7. PubMed ID: 5188805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.